Cost of achieving hba1c and weight loss treatment targets with ideglira vs insulin glargine u100 plus insulin aspart in the usa

  1. Billings, L.K.
  2. Mocarski, M.
  3. Basse, A.
  4. Hunt, B.
  5. Valentine, W.J.
  6. Jodar, E.
Revista:
ClinicoEconomics and Outcomes Research

ISSN: 1178-6981

Any de publicació: 2019

Volum: 11

Pàgines: 271-282

Tipus: Article

DOI: 10.2147/CEOR.S194719 GOOGLE SCHOLAR lock_openAccés obert editor